Clarinex Reditabs en es it fr

Clarinex Reditabs Brand names, Clarinex Reditabs Analogs

Clarinex Reditabs Brand Names Mixture

  • Clarinex-D 12 Hour Extended Release Tablets (desloratadine + pseudoephedrine)

Clarinex Reditabs Chemical_Formula


Clarinex Reditabs RX_link

Clarinex Reditabs fda sheet

Clarinex_Reditabs FDA

Clarinex Reditabs msds (material safety sheet)

Clarinex Reditabs Synthesis Reference

No information avaliable

Clarinex Reditabs Molecular Weight

310.82 g/mol

Clarinex Reditabs Melting Point

No information avaliable

Clarinex Reditabs H2O Solubility

No information avaliable

Clarinex Reditabs State


Clarinex Reditabs LogP


Clarinex Reditabs Dosage Forms

Syrup; Tablet

Clarinex Reditabs Indication

For the relief of symptoms of seasonal allergic rhinitis, pruritus, reduction in the number of hives in patients with chronic idiopathic urticaria.

Clarinex Reditabs Pharmacology

Desloratadine is a long-lasting antihistamine. Desloratadine is a second-generation H1-receptor antagonist which has a selective and peripheral H1-antagonist action. Histamine is a chemical that causes many of the signs that are part of allergic reactions, for example, swelling of tissues. Histamine is released from histamine-storing cells (mast cells) and attaches to other cells that have receptors for histamine. The attachment of the histamine to the receptors causes the cell to be "activated," releasing other chemicals which produce the effects that we associate with allergy. Desloratadine blocks one type of receptor for histamine (the H1 receptor) and thus prevents activation of cells by histamine. Unlike most other antihistamines, Desloratadine does not enter the brain from the blood and, therefore, does not cause drowsiness.

Clarinex Reditabs Absorption

No information avaliable

Clarinex Reditabs side effects and Toxicity

No information avaliable

Clarinex Reditabs Patient Information

No information avaliable

Clarinex Reditabs Organisms Affected

Humans and other mammals